Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1H-Pyrazole-3-carboxylicacid,5-methoxy-,ethylester(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

180518-75-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 180518-75-6 Structure
  • Basic information

    1. Product Name: 1H-Pyrazole-3-carboxylicacid,5-methoxy-,ethylester(9CI)
    2. Synonyms: 1H-Pyrazole-3-carboxylicacid,5-methoxy-,ethylester(9CI);5-Methoxy-1H-pyrazole-3-carboxylic acid ethyl ester
    3. CAS NO:180518-75-6
    4. Molecular Formula: C7H10N2O3
    5. Molecular Weight: 170.17
    6. EINECS: N/A
    7. Product Categories: GLYCINESCAFFOLD
    8. Mol File: 180518-75-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 328.1±22.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.220±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 10.08±0.10(Predicted)
    10. CAS DataBase Reference: 1H-Pyrazole-3-carboxylicacid,5-methoxy-,ethylester(9CI)(CAS DataBase Reference)
    11. NIST Chemistry Reference: 1H-Pyrazole-3-carboxylicacid,5-methoxy-,ethylester(9CI)(180518-75-6)
    12. EPA Substance Registry System: 1H-Pyrazole-3-carboxylicacid,5-methoxy-,ethylester(9CI)(180518-75-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 180518-75-6(Hazardous Substances Data)

180518-75-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 180518-75-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,5,1 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 180518-75:
(8*1)+(7*8)+(6*0)+(5*5)+(4*1)+(3*8)+(2*7)+(1*5)=136
136 % 10 = 6
So 180518-75-6 is a valid CAS Registry Number.

180518-75-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Methoxy-1H-pyrazole-3-carboxylic acid ethyl ester

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:180518-75-6 SDS

180518-75-6Relevant articles and documents

N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME

-

Page/Page column 417, (2021/02/12)

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain N-substituted-3,4-(fused 5-ring)-5-phenyl-pyrrolidin-2-one compounds (also referred to herein as "FRPPO compounds"), that, inter alia, inhibit glutaminyl-peptide cyclotransferase-like (isoQC) enzyme and/or glutaminyl-peptide cyclotransferase (QC) enzyme (e.g., inhibit or reduce or block the activity or function of isoQC and/or QC enzyme). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit isoQC and/or QC enzyme; to treat disorders that are ameliorated by the inhibition of isoQC and/or QC enzyme; to treat cancer, atherosclerosis, fibrotic diseases, infectious diseases, Alzheimer's disease, etc.

HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS

-

Page/Page column 135-136, (2021/02/19)

The present invention provides compounds of Formula (I) or a pharmaceutically acceptable salt thereof; (I) which are inhibitors of WDR5. The present invention also provides pharmaceutical compositions comprising such compounds, compositions comprising such compounds with an additional therapeutic agent and the therapeutic uses of such compounds.

Tricycles, their manufacture and use as pharmaceutical agents

-

Page/Page column 14, (2010/10/20)

The present invention relates to compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 180518-75-6